Detalles de la búsqueda
1.
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.
Diabetes Obes Metab
; 19(7): 1045-1050, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181728
2.
Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial).
PLoS One
; 16(11): e0259372, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34797832
3.
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.
JAMA Cardiol
; 3(2): 155-163, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29214305
4.
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials.
Diabetes Ther
; 8(3): 587-599, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432619
5.
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.
Diabetes Care
; 40(1): 69-76, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27797925
6.
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial.
Diabetes Care
; 39(8): 1329-37, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27222508
7.
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.
Eur Heart J Cardiovasc Pharmacother
; 2(3): 200-5, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27418973
8.
Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial.
Diabetes Care
; 38(11): 2142-50, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26358285
9.
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.
Diabetes Care
; 38(6): 1145-53, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25758769
10.
Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl peptidase-4 inhibitor saxagliptin.
Diabetes Care
; 37(9): 2435-41, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24914244
11.
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.
Thromb Res
; 127(2): 91-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21172721
Resultados
1 -
11
de 11
1
Próxima >
>>